Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 3/20 | 0.32 |
| ▸ | PPARD | Q03181 | 3/20 | 0.32 |
| ▸ | PPARA | Q07869 | 3/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL342623 | 1.00 | EP300 (0.35) | EP300CYP4F2CYP4A11CES2AKR1B1 | |
| SCHEMBL8676391 | 1.00 | EP300 (0.35) | EP300CYP4F2CYP4A11CES2AKR1B1 | |
| Maleic Acid SCHEMBL16685175 | 0.95 | HCAR2 (0.40) | HCAR2TDP1 | |
| SCHEMBL4016866 | 0.84 | EP300 (0.32) | EP300AKR1B1HCAR2ALOX15 | |
| SCHEMBL4016868 | 0.84 | EP300 (0.32) | EP300AKR1B1HCAR2ALOX15 | |
| SCHEMBL10008914 | 0.79 | EP300 (0.35) | EP300CES2AKR1B1HCAR2PPARG | |
| SCHEMBL9513413 | 0.77 | EP300 (0.39) | EP300CES2AKR1B1PPARGPPARD | |
| SCHEMBL2138523 | 0.74 | CYP4F2 (0.42) | CYP4F2CYP4A11CES2AKR1B1PPARG | |
| SCHEMBL3417789 | 0.74 | CYP4F2 (0.42) | CYP4F2CYP4A11CES2AKR1B1PPARG | |
| SCHEMBL10481805 | 0.74 | ACLY (0.36) | EP300AKR1B1HCAR2ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112754958-B | V73E modified shielding agent, preparation method and application thereof in skin care products | 上海迪摩化学科技有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-112754958-A | V73E modified shielding agent, preparation method and application thereof in skin care products | 上海迪摩化学科技有限公司 | 2021-05-07 | — | — | CN | claimed |
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | SOL-GEL TECHNOLOGIES LTD. (IL) | 2012-12-20 | — | — | US | claimed |
| EP-2324812-A2 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | Sol-Gel Technologies Ltd. (IL) | 2011-05-25 | — | — | EP | claimed |
| EP-1368057-B1 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | TORREY PINES INST (US) | 2009-08-26 | — | — | EP | claimed |
| US-7229621-B2 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2007-06-12 | — | — | US | claimed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1179024-B1 | ORGANOBORANE AMINE COMPLEX INITIATOR SYSTEMS AND POLYMERIZABLE COMPOSITIONS MADE THEREWITH | 3M INNOVATIVE PROPERTIES CO (US) | 2005-03-16 | — | — | EP | claimed |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | SOL-GEL TECHNOLOGIES LTD. (IL) | 2005-02-17 | — | — | US | claimed |
| EP-1071411-A4 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2004-12-08 | — | — | EP | claimed |
| WO-2003034979-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2003-05-01 | — | — | WO | claimed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | claimed |
| US-20020064541-A1 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | SOL-GEL TECHNOLOGIES LTD. (IL) | 2002-05-30 | — | — | US | claimed |
| WO-2001080823-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TROPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2001-11-01 | — | — | WO | claimed |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-09-27 | — | — | US | claimed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | claimed |
| EP-1071411-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2001-01-31 | — | — | EP | claimed |
| WO-1999053912-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-10-28 | — | — | WO | claimed |
| EP-0702059-B1 | Crosslinked polymer-powder compositions | WACKER CHEMIE GMBH (DE) | 1996-12-18 | — | — | EP | claimed |
| EP-0702059-A1 | Crosslinked polymer-powder compositions | Wacker-Chemie GmbH (DE) | 1996-03-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | GNG2, COG5, SQLE | EP300 1040/4885CYP4F2 4293/4885CYP4A11 1493/4885 |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | CD69, CD74, LY96 | EP300 1330/4885CYP4F2 2949/4885CYP4A11 3220/4885 |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | GNG2, COG5, SQLE | EP300 1040/4885CYP4F2 4293/4885CYP4A11 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.